Pharmaceutical innovation is the energy to upgrade the industrial structure. The First Guangzhou Multinational Pharmaceutical R&D Summit, which is co-hosted by Guangzhou Service Center for Scholarly Exchange and Guangzhou Bioengineering Center, was successfully held at Guangzhou Doubletree Hotel on December 19, 2014. Dr. Chunlin Chen, Medicilon CEO, was invited to participate as one of the speakers and panelists.
During the summit, Dr. Chen discussed with the other five expert panelists on the topics, “New Models of Collaboration” and “How to develop between the innovative environment and Guangzhou pharmaceutical industry?” Beside, the panel discussion, Dr. Chen also gave a speech with the topic, “The New Model of Drug Development, IP-CRO-Local Pharmaceutical Companies or IP-CRO-VC’s collaboration.”